---
figid: PMC6207586__fimmu-09-02237-g0006
figtitle: Mechanism of action of microtitre plate based complement activation assays
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Ovis aries
- Rattus norvegicus
- Cavia porcellus
- Neisseria meningitidis
- Sugarcane Ramu stunt disease phytoplasma
- Homo sapiens
- Lareunionomyces loeiensis
organisms_ner:
- Bos taurus
- Oryctolagus cuniculus
- Rattus norvegicus
- Cavia porcellus
- Homo sapiens
- Ovis aries
- Danio rerio
pmcid: PMC6207586
filename: fimmu-09-02237-g0006.jpg
figlink: /pmc/articles/PMC6207586/figure/F6/
number: F6
caption: Mechanism of action of microtitre plate based complement activation assays.
  Schematic representation of the mechanisms for commercially available enzyme immune
  assays (EIA) to monitor complement activation via the three different pathways.
  Wells of microtiter plates are coated with ligands for the recognition molecules
  within each pathway. For each assay, serum supplemented with inhibitors for the
  other two pathways is incubated. After complement activation, the readout for all
  assays is formation of the terminal complement complex C5b-9.
papertitle: Interpretation of Serological Complement Biomarkers in Disease.
reftext: Kristina N. Ekdahl, et al. Front Immunol. 2018;9:2237.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6699632
figid_alias: PMC6207586__F6
figtype: Figure
redirect_from: /figures/PMC6207586__F6
ndex: 6980f0c0-df35-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6207586__fimmu-09-02237-g0006.html
  '@type': Dataset
  description: Mechanism of action of microtitre plate based complement activation
    assays. Schematic representation of the mechanisms for commercially available
    enzyme immune assays (EIA) to monitor complement activation via the three different
    pathways. Wells of microtiter plates are coated with ligands for the recognition
    molecules within each pathway. For each assay, serum supplemented with inhibitors
    for the other two pathways is incubated. After complement activation, the readout
    for all assays is formation of the terminal complement complex C5b-9.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MBL2
  - C3
  - C5
  - C6
  - C7
  - C9
  - Igh-6
  - CD40LG
  - IRF6
  - MBL3P
  - MASP1
  - ERVK-3
  - ERVK-2
  - C5AR1
  - CSH2
  - ERCC6
  - C8A
  - C8B
  - C8G
  - lectin
  - hbl1
  - mbl2
  - c3a.2
  - c4
  - c3a.1
  - c5
  - ercc6
  - c6
  - c9
  - FB
  - LPS
---
